Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Chrisofos

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Journal of Clinical Medicine|December 17, 2024
Proteomics and Metabolomics in Varicocele-Associated Male Infertility: Advancing Precision Diagnostics and TherapyAris Kaltsas, Athanasios Zikopoulos, Eleftheria Markou, et al.
International Journal of Antimicrobial Agents|February 6, 2008
The impact of multidrug resistance on the pathogenicity of Escherichia coli: an experimental studyMagdalini Bristianou, Charalambos Panagou, Theodoros Adamis, et al.
Journal of Clinical Medicine|May 25, 2024
Advanced Paternal Age in Focus: Unraveling Its Influence on Assisted Reproductive Technology OutcomesAris Kaltsas, Athanasios Zikopoulos, Dionysios Vrachnis, et al.
Anticancer Research|April 22, 2011
Time to castration resistance is an independent predictor of castration-resistant prostate cancer survivalEvangelos Bournakis, Eleni Efstathiou, Andreas Varkaris, et al.
Journal of Cancer Research and Clinical Oncology|February 14, 2009
Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapyIoannis Zachos, Panagiotis A Konstantinopoulos, Gerasimos P Vandoros, et al.
The Journal of Urology|April 1, 2014
Immunomodulatory intervention with interferon-γ in Escherichia coli pyelonephritisMatthew P Katsaris, Theodoros Adamis, Aikaterini Pistiki, et al.
BMC Infectious Diseases|May 31, 2018
Progression into sepsis: an individualized process varying by the interaction of comorbidities with the underlying infectionDimitrios Sinapidis, Vassileios Kosmas, Vasileios Vittoros, et al.
Pharmacogenomics|November 15, 2012
Association of ERCC1 SNPs with outcome in platinum-treated patients with advanced urothelial cancer: a Hellenic Cooperative Oncology Group studyNikitas Nikitas, Alexandra Karadimou, Eliza Tsitoura, et al.
Shock (Augusta, Ga.)|September 19, 2006
Oleuropein: a novel immunomodulator conferring prolonged survival in experimental sepsis by Pseudomonas aeruginosaEvangelos J Giamarellos-Bourboulis, Taxiarchis Geladopoulos, Michael Chrisofos, et al.
Urology|January 25, 2011
Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancerIoannis Mountzios, Evangelos Bournakis, Eleni Efstathiou, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|December 17, 2024
Proteomics and Metabolomics in Varicocele-Associated Male Infertility: Advancing Precision Diagnostics and TherapyAris Kaltsas, Athanasios Zikopoulos, Eleftheria Markou, et al.
International Journal of Antimicrobial Agents|February 6, 2008
The impact of multidrug resistance on the pathogenicity of Escherichia coli: an experimental studyMagdalini Bristianou, Charalambos Panagou, Theodoros Adamis, et al.
Journal of Clinical Medicine|May 25, 2024
Advanced Paternal Age in Focus: Unraveling Its Influence on Assisted Reproductive Technology OutcomesAris Kaltsas, Athanasios Zikopoulos, Dionysios Vrachnis, et al.
Anticancer Research|April 22, 2011
Time to castration resistance is an independent predictor of castration-resistant prostate cancer survivalEvangelos Bournakis, Eleni Efstathiou, Andreas Varkaris, et al.
Journal of Cancer Research and Clinical Oncology|February 14, 2009
Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapyIoannis Zachos, Panagiotis A Konstantinopoulos, Gerasimos P Vandoros, et al.
The Journal of Urology|April 1, 2014
Immunomodulatory intervention with interferon-γ in Escherichia coli pyelonephritisMatthew P Katsaris, Theodoros Adamis, Aikaterini Pistiki, et al.
BMC Infectious Diseases|May 31, 2018
Progression into sepsis: an individualized process varying by the interaction of comorbidities with the underlying infectionDimitrios Sinapidis, Vassileios Kosmas, Vasileios Vittoros, et al.
Pharmacogenomics|November 15, 2012
Association of ERCC1 SNPs with outcome in platinum-treated patients with advanced urothelial cancer: a Hellenic Cooperative Oncology Group studyNikitas Nikitas, Alexandra Karadimou, Eliza Tsitoura, et al.
Shock (Augusta, Ga.)|September 19, 2006
Oleuropein: a novel immunomodulator conferring prolonged survival in experimental sepsis by Pseudomonas aeruginosaEvangelos J Giamarellos-Bourboulis, Taxiarchis Geladopoulos, Michael Chrisofos, et al.
Urology|January 25, 2011
Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancerIoannis Mountzios, Evangelos Bournakis, Eleni Efstathiou, et al.
Pageof 8